Optimus Medical Group | ClinicalTrials HQ

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine	brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder	Recruiting	Phase 3	2026-10-07		NCT07816367
Pre-Exposure Prophylaxis Study of Lenacapavir in Cisgender Men, Transgender Women, Transgender Men, and Gender Nonbinary People at Risk for HIV Infection	Pre-Exposure Prophylaxis of HIV Infection	Active, not recruiting	Phase 3	2026-10-06		NCT04925752
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1	HIV-1-infection	Recruiting	Phase 2	2026-09-04		NCT07645287
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy	Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Recruiting	Phase 3	2026-08-14		NCT07682961
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1	HIV-1-infection	Active, not recruiting	Phase 3	2026-04-30		NCT06630286
A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection	HIV-1 Infection	Active, not recruiting	Phase 2	2026-04-27		NCT05729568
Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIV	HIV-1 Infection	Active, not recruiting	Phase 2	2026-02-04		NCT05052996